Suramin, an anti-trypanosomal agent, has gained attention for its potential anticancer activity, partly through the modulation of RNA-binding proteins such as HuR. However, its genome-wide transcriptomic effects in oral squamous cell carcinoma remain unclear. ... ...

请注册登录后继续浏览